Title : APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells.

Pub. Date : 2015 Jun 18

PMID : 26086967






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 APR-246 is a prodrug that is converted to the active compound methylene quinuclidinone (MQ), a Michael acceptor that binds to cysteine residues in mutant p53 and restores its wild-type conformation. Cysteine tumor protein p53 Homo sapiens
2 We propose that this unique ability of APR-246/MQ to bind to cysteines in both mutant p53 and glutathione has a key role in the resensitization as well as in the outstanding synergistic effects observed with APR-246 in combination with platinum compounds in ovarian cancer cell lines and primary cancer cells. Cysteine tumor protein p53 Homo sapiens